Replies to post #33298 on Revive Therapeutics Ltd (RVVTF)

[Gatorca]

Tdr tweet. Just to add: some investors believed Revive was headed to a DSMB meeting first because of the ambiguous nature of last PR. IMO this PR shows that the company realizes it's more desirable to get a FDA consensus on EPs 1st, rather than deferring to the DSMB for a verdict. Agreed.

Just to add: some investors believed Revive was headed to a DSMB meeting first because of the ambiguous nature of last PR. IMO this PR shows that the company realizes it's more desirable to get a FDA consensus on EPs 1st, rather than deferring to the DSMB for a verdict. Agreed.

— The Dales Report (@TheDalesReport) October 6, 2022

[Classic Warrior]

I like "Submission of revised protocol next week." The specific timetable is now out there. Now, let's meet it and see fireworks.

ps. The drug not working is not going to be the reason if this stock fails. You and I both know that. Let's get em.